Correlation Between Allogene Therapeutics and Biomx
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Biomx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Biomx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Biomx Inc, you can compare the effects of market volatilities on Allogene Therapeutics and Biomx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Biomx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Biomx.
Diversification Opportunities for Allogene Therapeutics and Biomx
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Allogene and Biomx is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Biomx Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomx Inc and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Biomx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomx Inc has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Biomx go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and Biomx
Given the investment horizon of 90 days Allogene Therapeutics is expected to under-perform the Biomx. But the stock apears to be less risky and, when comparing its historical volatility, Allogene Therapeutics is 2.46 times less risky than Biomx. The stock trades about -0.04 of its potential returns per unit of risk. The Biomx Inc is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 255.00 in Biomx Inc on August 26, 2024 and sell it today you would lose (201.00) from holding Biomx Inc or give up 78.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allogene Therapeutics vs. Biomx Inc
Performance |
| Timeline |
| Allogene Therapeutics |
| Biomx Inc |
Allogene Therapeutics and Biomx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and Biomx
The main advantage of trading using opposite Allogene Therapeutics and Biomx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Biomx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomx will offset losses from the drop in Biomx's long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| Biomx vs. ZyVersa Therapeutics | Biomx vs. Immix Biopharma | Biomx vs. Cns Pharmaceuticals | Biomx vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world |